Columbia Care Inc. (NEO: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest fully integrated operators in the global medical cannabis industry with licenses across the US and EU, announced today a collaboration with IPS Specials, an experienced compounding pharmaceutical manufacturer, importer and distributor of unlicensed “specials” and licensed medicines […]
The post Columbia Care Announces Collaboration with IPS Specials and Grow Biotech to Import BeneCeed™ Tablets to the United Kingdom for Clinical Study appeared first on Technical420.
You may also like
-
Are These Cannabis Stocks A Buy This Week? Pot Stocks For Your Watchlist Right Now
-
Fire & Flower Holdings Corp. (FFLWF) World’s First Non-Fungible Toke in Celebration of 420
-
Jushi Holdings Inc.(JUSHF) Announces Purchase of Dalitso LLC Facility and Land in Prince William County, VA
-
Pure Extracts Commences Initial Production Run of 50,000 Gummie Packs for Provincial Distribution
-
Canopy Growth Corporation (CGC) Introduces Vert – a Quebec-Exclusive Cannabis Brand